Jialin Mao

Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions

Tatsuki Mochizuki, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida et al. · Clinical Pharmacology & Therapeutics · 2022 · 34 citations · Full text

Physiologically‐based pharmacokinetic model‐based translation of <scp>OATP1B</scp>‐mediated drug–drug interactions from coproporphyrin I to probe drugs

Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado et al. · Clinical and Translational Science · 2022 · 30 citations · Full text

Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction

Yuan Chen, Fang Ma, Tong Lu et al. · Clinical Pharmacokinetics · 2015 · 24 citations

Drug Interactions, Pharmacokinetic Modeling, Pharmacodynamics +9

Physiologically Based Pharmacokinetic Model‐Informed Drug Development for Polatuzumab Vedotin: Label for Drug‐Drug Interactions Without Dedicated Clinical Trials

Divya Samineni, Hao Ding, Fang Ma et al. · The Journal of Clinical Pharmacology · 2020 · 21 citations

Translational and pharmacokinetic‐pharmacodynamic application for the clinical development of GDC‐0334, a novel TRPA1 inhibitor

Phyllis Chan, Han Ting Ding, Bianca M. Liederer et al. · Clinical and Translational Science · 2021 · 20 citations · Full text

Immunology, Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling +19